Committed to Advancing TAVR
ABOUT HLTOur Mission: HLT is committed to advancing TAVR (Transcatheter Aortic Valve Replacement) therapies to improve lives. Quality is the foundation of our culture, entrusting personnel to maintain an effective Quality Management System and a commitment to comply with customer and regulatory requirements.
Resourced for Innovation
HLT is a part of the Bracco Group, an Italy-based, multinational healthcare company operating in over 100 countries worldwide with revenues exceeding €1.3B. Bracco invests a significant amount of its resources in research and innovation across its portfolio of companies to improve patient outcomes and optimize treatment procedures.
World Class Expertise
With global headquarters in Minnesota, USA, HLT employs highly experienced healthcare and device industry professionals working in a creative, collaborative, and entrepreneurial environment.
Focused Agility
We pride ourselves on innovating for specific unmet clinical needs and rapidly responding to technological change.
The HLT Meridian® TAVR Valve System is intended to provide:

Procedural Flexibility
Reposition the valve and assess full hemodynamic function prior to final valve release.

Durability by Design
Achieve coaptation and reduced commissure stress, regardless of native annulus shape.

Fully Retrievable
Retrieve the valve prior to final release for better outcomes and lower complications.

Low-profile Design
Reposition the valve and assess full hemodynamic function prior to final valve release.

About transcatheter aortic valve replacement (TAVR) and aortic stenosis
Transcatheter aortic valve replacement treats one of the most common heart valve diseases, aortic stenosis, which is a narrowing of the aortic valve that obstructs blood flow from the heart.

Watch the full animation
Surgical aortic valve replacement (SAVR) is the current standard treatment for patients with severe symptomatic aortic stenosis. However a less-invasive approach, transcatheter aortic valve replacement (TAVR), is now considered as a way to replace the diseased aortic valve without open heart surgery for this patient population.
The TAVR procedure involves making a small incision in the upper leg and navigating a replacement valve into the heart.